U.S. Not Far From Having Widely-Available Virus Testing: ProHEALTH

The transcript discusses the capacity for widespread COVID-19 testing, comparing China's efforts to those in the US. It highlights the importance of testing in safely reopening economies and the challenges of antibody testing reliability. The conversation also covers the availability of tests for symptomatic and asymptomatic individuals, the role of government in coordinating resources, and the need for a gradual reopening strategy based on current data and safety measures.

How does the availability of testing impact the management of asymptomatic cases?

What role does the government play in the testing and reopening process?

What is the significance of having a partnership between doctors and patients regarding testing?